Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Daxor Corp DXR

Healthcare Medical Devices
Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific... see more

Recent & Breaking News (NDAQ:DXR)

DAXOR'S INNOVATIVE BVA-100(TM) BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24

GlobeNewswire October 9, 2024

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire October 8, 2024

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device

GlobeNewswire September 27, 2024

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024

GlobeNewswire September 19, 2024

Newly Published Review Highlights the Pivotal Role of Daxor's Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management

GlobeNewswire September 12, 2024

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee

GlobeNewswire September 5, 2024

Leading Central Florida Hospital Implements Daxor's BVA-100(TM) Blood Volume Diagnostic for Heart Failure Patient Care

GlobeNewswire September 4, 2024

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

GlobeNewswire September 3, 2024

Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 3, 2024

Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network

GlobeNewswire August 29, 2024

Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer

GlobeNewswire August 6, 2024

Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide

GlobeNewswire August 5, 2024

Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer

GlobeNewswire July 24, 2024

Daxor Corporation's BVA-100(TM) Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide

GlobeNewswire July 11, 2024

Daxor Corporation to Showcase the Benefits of BVA-100(TM) Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting

GlobeNewswire June 18, 2024

Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

GlobeNewswire June 5, 2024

New Studies Prove the Clinical Benefits of Daxor's Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion

GlobeNewswire April 16, 2024

DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING'24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR'S BLOOD VOLUME DIAGNOSTIC (BVA-100(TM))

GlobeNewswire April 15, 2024

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital

GlobeNewswire April 10, 2024

Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24

GlobeNewswire April 1, 2024